Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models

By R. Skouta, Scott J. Dixon, Jianlin Wang, Denise E. Dunn, M. Orman, K. Shimada, P. Rosenberg, D. Lo, J. Weinberg, A. Linkermann and 1 more. Journal of the American Chemical Society, 2014

1,009 citations recorded by the source corpus.

Ferrostatin-1 (Fer-1) inhibits ferroptosis, a form of regulated, oxidative, nonapoptotic cell death. We found that Fer-1 inhibited cell death in cellular models of Huntington’s disease (HD), periventricular leukomalacia (PVL), and kidney dysfunction; Fer-1 inhibited lipid peroxidation, but not mitochondrial reactive oxygen species formation or lysosomal membrane permeability. We developed a mechanistic model to explain the activity of Fer-1, which guided the development of ferrostatins with improved properties. These studies suggest numerous therapeutic uses for ferrostatins, and that lipid peroxidation mediates diverse disease phenotypes.

Subfields: Molecular Biology, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/12a74ab908bba83792fc8a3da05487966a2bad1d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

  1. Guido Kroemer
  2. Brent R. Stockwell
  3. D. Tang
  4. R. Kang
  5. Douglas R. Green
  6. L. Galluzzi
  7. Beth Levine
  8. Simone Fulda

In Nutrition and Dietetics

  1. Brent R. Stockwell
  2. D. Tang
  3. R. Kang
  4. Scott J. Dixon
  5. W. Yang
  6. M. Conrad
  7. J. Cao
  8. Guido Kroemer

Citations in the corpus